If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

BGNE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $8,840,091.52

BeiGene Insider Trading History Chart

BeiGene Share Price & Price History

^$137.14

▲ +2.32 (1.72%)

As of 10/3/2022 06:22 PM ET

Days: 30 | 90 | 365

Top 5 Stocks to Double in 2022

From Market Moving Trends | Ad

Reach Your Investing Goals with These 5 Stocks… Sign Up for your Free Report: Top 5 Stocks to Double in 2022.

>>>

BeiGene Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/20/2022	John Oyler	CEO	Sell	30,520	$153.50	$4,684,820.00	2,070,913
7/1/2022	Julia Aijun Wang	CFO	Sell	295	$158.50	$46,757.50
6/27/2022	Lai Wang	insider	Sell	458	$177.32	$81,212.56
6/21/2022	Lai Wang	insider	Sell	723	$149.01	$107,734.23
6/21/2022	Xiaobin Wu	COO	Sell	1,010	$144.36	$145,803.60
6/17/2022	Julia Aijun Wang	CFO	Sell	161	$136.64	$21,999.04
6/17/2022	Lai Wang	Insider	Sell	445	$139.40	$62,033.00	723
6/17/2022	Xiaobin Wu	COO	Sell	578	$139.60	$80,688.80	1,010
6/6/2022	Lai Wang	insider	Sell	660	$142.00	$93,720.00
6/6/2022	Xiaobin Wu	COO	Sell	3,410	$141.99	$484,185.90
5/5/2022	Xiaobin Wu	COO	Sell	6,725	$164.35	$1,105,253.75
12/14/2021	Jane Huang	CMO	Sell	1,500	$278.14	$417,210.00
12/1/2021	Jane Huang	CMO	Sell	1,049	$359.86	$377,493.14
11/17/2021	Jane Huang	CMO	Sell	1,500	$381.34	$572,010.00
10/19/2021	Jane Huang	CMO	Sell	1,500	$372.78	$559,170.00
9/24/2021	Ltd. Beigene	Major Shareholder	Buy	2,543,800	$2.85	$7,249,830.00
9/20/2021	Jane Huang	CMO	Sell	6,000	$397.96	$2,387,760.00
9/14/2021	John Oyler	CEO	Sell	195,477	$93.87	$18,349,425.99	2,267,161
9/13/2021	Jane Huang	CMO	Sell	12,901	$358.14	$4,620,364.14	145,235
9/10/2021	Amgen Inc	Major Shareholder	Buy	165,529	$302.06	$49,999,689.74
9/2/2021	John Oyler	CEO	Sell	24,499	$328.21	$8,040,816.79	3,694,720
9/1/2021	Jane Huang	CMO	Sell	542	$310.53	$168,307.26	305,824
8/31/2021	John Oyler	CEO	Sell	111,081	$110.13	$12,233,350.53
8/4/2021	John Oyler	CEO	Sell	80,847	$150.97	$12,205,471.59	4,385,979
7/22/2021	John Oyler	CEO	Sell	69,216	$71.82	$4,971,093.12	5,849,945
7/20/2021	John Oyler	CEO	Sell	43,695	$132.26	$5,779,100.70	5,849,945
7/15/2021	Jane Huang	CMO	Sell	21,000	$332.42	$6,980,820.00	298,661
7/7/2021	John Oyler	CEO	Sell	300	$325.23	$97,569.00
7/6/2021	Xiaobin Wu	COO	Sell	10,180	$325.53	$3,313,895.40	1,081,389
7/1/2021	Julia Aijun Wang	CFO	Sell	308	$349.06	$107,510.48
6/28/2021	Howard Liang	CFO	Sell	446	$365.00	$162,790.00	1,553,149
6/28/2021	Lai Wang	Insider	Sell	455	$362.48	$164,928.40
6/18/2021	Xiaobin Wu	COO	Sell	1,156	$330.93	$382,555.08
6/9/2021	Timothy Yung-Cheng Chen	Director	Sell	3,164	$351.35	$1,111,671.40	3,164
6/7/2021	Howard Liang	CFO	Sell	650	$354.16	$230,204.00	1,565,265
6/7/2021	Jane Huang	CMO	Sell	603	$351.55	$211,984.65	284,933
6/7/2021	Lai Wang	Insider	Sell	656	$354.26	$232,394.56	195,455
6/7/2021	Xiaobin Wu	COO	Sell	3,398	$352.54	$1,197,930.92	1,150,757
6/1/2021	Jane Huang	CMO	Sell	540	$362.64	$195,825.60	292,772
5/28/2021	Jane Huang	CMO	Sell	1,500	$356.30	$534,450.00	292,772
5/10/2021	Xiaodong Wang	Insider	Sell	3,394	$300.46	$1,019,761.24	5,747,271
5/3/2021	Xiaobin Wu	COO	Sell	6,715	$343.00	$2,303,245.00
4/29/2021	Jane Huang	CMO	Sell	1,500	$354.92	$532,380.00	285,583
3/29/2021	Jane Huang	CMO	Sell	1,500	$324.00	$486,000.00	285,583
1/29/2021	Jane Huang	CMO	Sell	1,500	$322.99	$484,485.00	285,583
1/15/2021	Howard Liang	CFO	Sell	12,600	$344.90	$4,345,740.00	1,573,715
1/4/2021	Bros. Advisors Lp Baker	Director	Sell	121,154	$220.50	$26,714,457.00
12/29/2020	Jane Huang	CMO	Sell	1,500	$249.13	$373,695.00	285,583
12/14/2020	Howard Liang	CFO	Sell	91,900	$229.04	$21,048,776.00	1,573,715
11/30/2020	Jane Huang	CMO	Sell	1,500	$267.82	$401,730.00	285,583
10/29/2020	Jane Huang	CMO	Sell	1,500	$300.06	$450,090.00	285,583
10/16/2020	Xiaodong Wang	Insider	Sell	5,000	$320.00	$1,600,000.00	7,201,009
10/5/2020	Howard Liang	CFO	Sell	14,000	$299.60	$4,194,400.00	168,415
10/5/2020	Xiaodong Wang	Insider	Sell	5,000	$300.00	$1,500,000.00	7,201,009
9/29/2020	Jane Huang	CMO	Sell	1,500	$280.38	$420,570.00	285,583
9/29/2020	John Oyler	CEO	Sell	54,303	$280.39	$15,226,018.17	8,927,570
9/25/2020	Xiaodong Wang	Insider	Sell	5,000	$280.42	$1,402,100.00	7,201,009
9/17/2020	Xiaodong Wang	Insider	Sell	5,000	$260.27	$1,301,350.00	7,201,009
9/16/2020	John Oyler	CEO	Sell	27,275	$254.77	$6,948,851.75	9,633,509
9/14/2020	Howard Liang	CFO	Sell	14,000	$250.27	$3,503,780.00	168,415
9/14/2020	John Oyler	CEO	Sell	19,739	$250.25	$4,939,684.75	9,633,509
9/3/2020	Jane Huang	CMO	Sell	3,128	$233.07	$729,042.96	285,583
9/2/2020	John Oyler	CEO	Sell	61,042	$233.21	$14,235,604.82	10,689,473
8/31/2020	John Oyler	CEO	Sell	12,961	$240.86	$3,121,786.46	10,689,473
8/28/2020	Jane Huang	CMO	Sell	3,000	$242.21	$726,630.00	326,247
8/21/2020	John Oyler	CEO	Sell	40,788	$240.19	$9,796,869.72	11,483,019
8/19/2020	John Oyler	CEO	Sell	29,866	$234.56	$7,005,368.96	11,483,019
8/14/2020	John Oyler	CEO	Sell	8,705	$211.15	$1,838,060.75	12,681,320
8/12/2020	John Oyler	CEO	Sell	19,820	$212.10	$4,203,822.00	12,681,320
8/11/2020	Timothy Yung-Cheng Chen	Director	Sell	1,903	$213.04	$405,415.12	2,200
8/10/2020	Xiaodong Wang	Insider	Sell	4,000	$211.06	$844,240.00	7,201,009
8/5/2020	John Oyler	CEO	Sell	17,254	$223.27	$3,852,300.58	13,239,904
8/3/2020	John Oyler	CEO	Sell	25,176	$221.78	$5,583,533.28	13,464,206
7/29/2020	Jane Huang	CMO	Sell	3,000	$209.93	$629,790.00	326,247
7/22/2020	John Oyler	CEO	Sell	27,748	$238.34	$6,613,458.32	13,991,473
7/20/2020	John Oyler	CEO	Sell	28,762	$251.85	$7,243,709.70	14,352,197
7/20/2020	Xiaobin Wu	Insider	Sell	3,300	$249.22	$822,426.00	1,423,562
7/17/2020	Xiaobin Wu	Insider	Sell	700	$245.74	$172,018.00	1,423,562
7/15/2020	Xiaobin Wu	Insider	Sell	2,700	$241.11	$650,997.00	1,466,462
7/13/2020	Xiaobin Wu	Insider	Sell	3,000	$220.00	$660,000.00	1,466,462
7/8/2020	John Oyler	CEO	Sell	17,529	$201.39	$3,530,165.31	15,069,472
7/7/2020	Jane Huang	CMO	Sell	3,921	$200.00	$784,200.00	326,247
7/7/2020	Xiaodong Wang	Insider	Sell	6,000	$200.00	$1,200,000.00	7,267,569
7/6/2020	John Oyler	CEO	Sell	17,362	$197.11	$3,422,223.82	15,069,472
7/1/2020	John Oyler	CEO	Sell	3,816	$191.57	$731,031.12	15,770,354
6/29/2020	Howard Liang	CFO	Sell	300	$191.23	$57,369.00	168,415
6/29/2020	Jane Huang	CMO	Sell	1,935	$190.83	$369,256.05	326,247
6/29/2020	John Oyler	CEO	Sell	1,435	$192.60	$276,381.00	15,770,354
6/26/2020	Jane Huang	CMO	Sell	2,079	$200.29	$416,402.91	326,247
6/24/2020	John Oyler	CEO	Sell	14,381	$187.34	$2,694,136.54	15,838,617
6/22/2020	John Oyler	CEO	Sell	10,281	$182.43	$1,875,562.83	15,838,617
6/22/2020	Xiaodong Wang	Insider	Sell	5,000	$181.33	$906,650.00	7,330,580
6/8/2020	Howard Liang	CFO	Sell	453	$170.84	$77,390.52	116,428
6/8/2020	Jane Huang	CMO	Sell	631	$170.84	$107,800.04	283,464
6/8/2020	Xiaobin Wu	Insider	Sell	2,800	$170.83	$478,324.00	1,380,415
5/29/2020	Jane Huang	CMO	Sell	1,500	$163.86	$245,790.00	291,667
5/19/2020	Donald W. Glazer	Director	Sell	10,000	$169.84	$1,698,400.00	3,497,678
5/1/2020	John Oyler	CEO	Sell	4,635	$141.43	$655,528.05	16,366,833
5/1/2020	Xiaobin Wu	Insider	Sell	7,024	$141.33	$992,701.92
4/29/2020	Jane Huang	CMO	Sell	1,500	$162.30	$243,450.00	291,667
4/16/2020	Jane Huang	CMO	Sell	1,500	$160.00	$240,000.00	291,667
3/4/2020	Xiaodong Wang	Insider	Sell	5,000	$157.14	$785,700.00	7,395,580
1/21/2020	Jane Huang	CMO	Sell	1,500	$170.69	$256,035.00	291,667
12/17/2019	John Oyler	CEO	Sell	62,259	$160.62	$10,000,040.58	16,411,788
12/16/2019	Jane Huang	CMO	Sell	1,500	$165.14	$247,710.00	291,667
11/18/2019	Howard Liang	CFO	Sell	25,000	$194.34	$4,858,500.00	122,317
11/18/2019	Jane Huang	CMO	Sell	1,500	$194.49	$291,735.00	291,667
11/14/2019	Xiaodong Wang	Insider	Sell	8,504	$193.31	$1,643,908.24	7,460,580
11/5/2019	Timothy Yung-Cheng Chen	Director	Sell	3,800	$189.15	$718,770.00	4,000
11/4/2019	Jane Huang	CMO	Sell	32,900	$190.46	$6,266,134.00	291,667
11/4/2019	Xiaodong Wang	Insider	Sell	1,000	$190.00	$190,000.00	7,585,628
11/1/2019	Xiaodong Wang	Insider	Sell	1,000	$170.00	$170,000.00	7,585,628

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for BeiGene (NASDAQ:BGNE)

51.77% of BeiGene stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BeiGene Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/2/2022	Amundi	87,679	$15.43M	0.0%	-3.2%	0.085%
8/25/2022	M&G Investment Management Ltd.	111,860	$18.12M	0.1%	+72.5%	0.108%
8/22/2022	Legal & General Group Plc	284,661	$46.07M	0.0%	+10.9%	0.275%
8/18/2022	Goldman Sachs Group Inc.	243,293	$39.38M	0.0%	+1.9%	0.235%
8/17/2022	Nomura Holdings Inc.	6,620	$1.07M	0.0%	+24.4%	0.006%
8/17/2022	Macquarie Group Ltd.	23,071	$3.73M	0.0%	-28.6%	0.022%
8/17/2022	National Pension Service	10,182	$1.65M	0.0%	+1,099.3%	0.010%
8/16/2022	First Republic Investment Management Inc.	6,814	$1.10M	0.0%	-1.0%	0.007%
8/16/2022	Price T Rowe Associates Inc. MD	462,144	$74.80M	0.0%	-12.2%	0.447%
8/15/2022	AQR Capital Management LLC	77,611	$12.56M	0.0%	-0.4%	0.075%
8/15/2022	State Street Corp	766,690	$124.09M	0.0%	-8.2%	0.741%
8/15/2022	Macquarie Group Ltd.	23,071	$3.73M	0.0%	-28.6%	0.022%
8/15/2022	Seaport Global Advisors LLC	2,266	$0.37M	1.4%	-7.8%	0.002%
8/15/2022	Cubist Systematic Strategies LLC	7,489	$1.21M	0.0%	+235.5%	0.007%
8/15/2022	Millennium Management LLC	36,228	$5.86M	0.0%	+126.4%	0.035%
8/15/2022	Sei Investments Co.	11,736	$1.90M	0.0%	+110.1%	0.011%
8/15/2022	UBS Asset Management Americas Inc.	188,005	$30.43M	0.0%	+1.7%	0.182%
8/13/2022	NewEdge Wealth LLC	1,797	$0.29M	0.0%	N/A	0.002%
8/13/2022	Quantbot Technologies LP	3,800	$0.62M	0.1%	N/A	0.004%
8/13/2022	Teacher Retirement System of Texas	39,119	$6.33M	0.0%	-4.9%	0.038%
8/13/2022	Virtu Financial LLC	9,758	$1.58M	0.1%	N/A	0.009%
8/13/2022	Zurcher Kantonalbank Zurich Cantonalbank	23,017	$3.73M	0.0%	+9.9%	0.022%
8/13/2022	Wells Fargo & Company MN	69,392	$11.23M	0.0%	-2.6%	0.067%
8/13/2022	Caisse DE Depot ET Placement DU Quebec	13,956	$2.26M	0.0%	+199.7%	0.013%
8/12/2022	Northern Trust Corp	115,034	$18.62M	0.0%	+7.7%	0.111%
8/12/2022	Virtus ETF Advisers LLC	1,758	$0.29M	0.1%	+31.6%	0.002%
8/12/2022	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	19,300	$3.12M	0.0%	-5.7%	0.019%
8/12/2022	LPL Financial LLC	1,616	$0.26M	0.0%	-12.1%	0.002%
8/12/2022	Credit Suisse AG	78,541	$12.71M	0.0%	-32.0%	0.076%
8/12/2022	Edmond DE Rothschild Holding S.A.	67,900	$10.99M	0.3%	+4.5%	0.066%
8/12/2022	USS Investment Management Ltd	180,247	$29.20M	0.3%	+70.2%	0.174%
8/12/2022	Rafferty Asset Management LLC	1,647	$0.27M	0.0%	+15.0%	0.002%
8/12/2022	FMR LLC	2,892,763	$468.19M	0.0%	-15.3%	2.796%
8/12/2022	Korea Investment CORP	18,800	$3.04M	0.0%	-38.0%	0.018%
8/12/2022	Prudential PLC	2,156	$0.35M	0.0%	N/A	0.002%
8/12/2022	BNP Paribas Arbitrage SA	63,193	$10.23M	0.0%	-14.6%	0.061%
8/12/2022	United Capital Financial Advisers LLC	2,706	$0.44M	0.0%	-8.6%	0.003%
8/11/2022	Primecap Management Co. CA	4,031,449	$652.49M	0.6%	+8.7%	3.896%
8/11/2022	Bridgewater Associates LP	331,142	$53.60M	0.2%	-13.7%	0.320%
8/11/2022	Artal Group S.A.	650,000	$105.20M	5.6%	-2.3%	0.628%
8/11/2022	Trexquant Investment LP	1,682	$0.27M	0.0%	N/A	0.002%
8/11/2022	Deutsche Bank AG	100,762	$16.31M	0.0%	-1.5%	0.097%
8/11/2022	Healthcare of Ontario Pension Plan Trust Fund	39,810	$6.44M	0.0%	N/A	0.038%
8/11/2022	AIA Group Ltd	3,850	$0.62M	0.0%	+12.7%	0.004%
8/11/2022	UBS Group AG	17,367	$2.81M	0.0%	-79.5%	0.017%
8/11/2022	Bank of Montreal Can	80,062	$13.74M	0.0%	+449.5%	0.077%
8/11/2022	JPMorgan Chase & Co.	102,619	$16.61M	0.0%	-11.8%	0.099%
8/10/2022	California Public Employees Retirement System	110,059	$17.81M	0.0%	-45.0%	0.106%
8/10/2022	Desjardins Global Asset Management Inc.	1,523	$0.25M	0.0%	+7.6%	0.001%
8/9/2022	Mitsubishi UFJ Trust & Banking Corp	122,265	$19.79M	0.1%	-3.9%	0.118%
8/9/2022	Swiss National Bank	128,285	$20.76M	0.0%	-0.5%	0.124%
8/9/2022	Pictet Asset Management SA	308,919	$50M	0.1%	+301.5%	0.299%
8/9/2022	Shell Asset Management Co.	8,196	$1.33M	0.0%	-11.2%	0.008%
8/8/2022	Baird Financial Group Inc.	97,772	$15.82M	0.0%	+4.5%	0.095%
8/8/2022	Oppenheimer Asset Management Inc.	12,203	$1.98M	0.0%	+2.1%	0.012%
8/8/2022	Baillie Gifford & Co.	3,234,931	$523.57M	0.5%	-21.2%	3.129%
8/5/2022	NINE MASTS CAPITAL Ltd	3,469	$0.57M	0.2%	N/A	0.003%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	7,606	$1.23M	0.0%	+64.0%	0.007%
8/5/2022	OLD Mission Capital LLC	68,336	$11.06M	0.3%	+115.3%	0.066%
8/5/2022	abrdn plc	10,510	$1.70M	0.0%	+134.0%	0.010%
8/4/2022	Steward Partners Investment Advisory LLC	400	$65K	0.0%	N/A	0.000%
8/4/2022	Vestmark Advisory Solutions Inc.	3,034	$0.49M	0.0%	+78.6%	0.003%
8/4/2022	Aviva PLC	24,449	$3.96M	0.0%	+12.4%	0.024%
8/4/2022	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	78,262	$12.67M	0.0%	-53.1%	0.076%
8/4/2022	TD Asset Management Inc.	18,320	$2.97M	0.0%	-23.6%	0.018%
8/3/2022	Envestnet Asset Management Inc.	24,827	$4.02M	0.0%	+3.2%	0.024%
8/3/2022	Van ECK Associates Corp	99,966	$16.18M	0.0%	+7.1%	0.097%
8/3/2022	Assetmark Inc.	4,618	$0.75M	0.0%	+18.8%	0.004%
8/3/2022	DekaBank Deutsche Girozentrale	34,514	$5.45M	0.0%	+10.3%	0.033%
8/3/2022	Zeal Asset Management Ltd	189,847	$29.59M	61.0%	-2.6%	0.184%
8/3/2022	Handelsbanken Fonder AB	19,800	$3.21M	0.0%	+13.1%	0.019%
8/1/2022	US Bancorp DE	692	$0.11M	0.0%	-70.4%	0.001%
8/1/2022	ProShare Advisors LLC	3,830	$0.62M	0.0%	-25.7%	0.004%
8/1/2022	Profund Advisors LLC	9,062	$1.47M	0.1%	+6.3%	0.009%
7/29/2022	SG Americas Securities LLC	1,776	$0.29M	0.0%	-94.6%	0.002%
7/29/2022	Crossmark Global Holdings Inc.	2,502	$0.41M	0.0%	-14.1%	0.002%
7/29/2022	Russell Investments Group Ltd.	3,519	$0.57M	0.0%	-43.1%	0.003%
7/29/2022	Asset Management One Co. Ltd.	25,820	$4.18M	0.0%	-0.5%	0.025%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	91,891	$14.87M	0.0%	-6.8%	0.089%
7/26/2022	KBC Group NV	14,523	$2.35M	0.0%	+2.3%	0.014%
7/26/2022	Sumitomo Mitsui Trust Holdings Inc.	117,527	$19.02M	0.0%	+7.5%	0.114%
7/22/2022	LVW Advisors LLC	1,654	$0.27M	0.1%	-4.1%	0.002%
7/19/2022	Sawtooth Solutions LLC	3,269	$0.53M	0.1%	N/A	0.003%
7/18/2022	Veriti Management LLC	2,060	$0.33M	0.0%	N/A	0.002%
7/13/2022	E Fund Management Hong Kong Co. Ltd.	32,219	$5.22M	3.6%	+17.2%	0.031%
7/13/2022	Private Advisor Group LLC	3,407	$0.55M	0.0%	+194.7%	0.003%
6/24/2022	Temasek Holdings Private Ltd	2,966,463	$559.48M	2.3%	+0.3%	2.881%
6/7/2022	Bank of America Corp DE	414,466	$78.17M	0.0%	+77.1%	0.403%
6/2/2022	Mirae Asset Global Investments Co. Ltd.	98,639	$18.60M	0.0%	-13.8%	0.096%
5/20/2022	International Biotechnology Trust PLC	15,700	$11.40M	2.6%	-21.5%	0.015%
5/20/2022	The Manufacturers Life Insurance Company	20,175	$4.01M	0.0%	+155.4%	0.020%
5/19/2022	Capital International Sarl	172,972	$32.62M	1.6%	+38.3%	0.168%
5/19/2022	Capital Group International Inc. CA	1,140,960	$215.19M	2.4%	+14.1%	1.106%
5/19/2022	Capital International Investors	7,055,295	$1.34B	0.3%	+11.2%	6.838%
5/18/2022	BNP Paribas Arbitrage SA	73,973	$13.95M	0.0%	-16.9%	0.072%
5/17/2022	Advisors Asset Management Inc.	1,244	$0.24M	0.0%	+26.7%	0.001%
5/17/2022	Royal Bank of Canada	74,053	$13.97M	0.0%	+48.0%	0.072%
5/17/2022	First Republic Investment Management Inc.	6,882	$1.30M	0.0%	+43.9%	0.007%
5/16/2022	California State Teachers Retirement System	9,380	$1.77M	0.0%	-2.1%	0.009%
5/16/2022	Goldman Sachs Group Inc.	238,676	$45.01M	0.0%	+26.7%	0.232%

Data available starting January 2016

BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; XGEVA to treat giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; Pamiparib for the treatment of various solid tumors; and Pobevcy to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC). The company's clinical stage drug candidates comprise Zanubrutinib, a BTK inhibitor to treat lymphomas; Tislelizumab, an anti-PD-1 antibody to treat solid and hematological cancers; Lifirafenib and BGB-3245 to treat melanoma, NSCLC, and endometrial cancer; and Sitravatinib, a multi-kinase inhibitor to treat NSCLC, melanoma, and other solid tumors. Its clinical stage drug candidates also include BGB-A333, a PD-L1 inhibitor to treat various solid tumors; Ociperlimab, a TIGIT inhibitor to treat various solid tumors; BGB-11417, a small molecule Bcl-2 inhibitor to treat mature B-cell malignancies; BGB-A445, an OX40 agonist antibody to treat solid tumors; Zanidatamab, a bispecific HER2 inhibitor to treat breast and gastric cancer; BGB-A425, a T-cell immunoglobulin and mucin-domain containing-3 inhibitor to treat various solid tumors; and BGB-15025, a small molecule inhibitor of HPK1. The company has strategic collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, and Bristol Myers Squibb company. BeiGene, Ltd. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $137.14

$131.54

$139.24

50 Day Range

MA: $169.01

$131.80

$202.24

52 Week Range

Now: $137.14

$118.18

$392.30

Volume

213,651 shs

Average Volume

285,092 shs

Market Capitalization

$14.21 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.73

Who are the company insiders with the largest holdings of BeiGene?: BeiGene's top insider investors include:
Xiaodong Wang (Insider)
John Oyler (CEO)
Howard Liang (CFO)
Xiaobin Wu (COO)
Jane Huang (CMO)
Lai Wang (Insider)
Timothy Yung-Cheng Chen (Director)
Amgen Inc (Major Shareholder)
Bros Advisors Lp Baker (Director)
Julia Aijun Wang (CFO)
Ltd Beigene (Major Shareholder)
Learn More about top insider investors at BeiGene.